The share price of Israeli cancer treatment company Alpha Tau Medical (Nasdaq: DRTS) rose by 21% last week, following the ...
At the "Globes" Israel Business Conference a month ago, commenting on the company’s $435 million investment round in November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback